Literature DB >> 14375411

Experimental pseudomembranous enterocolitis; production by means of thrombosis of intestinal mucosal capillaries.

D G McKAY, R M HARDAWAY, G H WAHLE, R M HALL.   

Abstract

Entities:  

Keywords:  COLITIS; INTESTINES/diseases; THROMBOSIS/experimental

Mesh：

Year:  1955        PMID： 14375411     DOI： 10.1001/archinte.1955.00250120015002

Source DB:  PubMed          Journal:  AMA Arch Intern Med        ISSN： 0888-2479


× No keyword cloud information.
  9 in total

1.  Intravascular thrombi and the intestinal factor of irreversible shock.

Authors:  R M HARDAWAY; D G McKAY
Journal:  Ann Surg       Date:  1959-08       Impact factor: 12.969

2.  Disseminated intravascular coagulation: a cause of shock.

Authors:  R M HARDAWAY; D G McKAY
Journal:  Ann Surg       Date:  1959-04       Impact factor: 12.969

3.  Diagnosis of staphylococcal enteritis.

Authors:  N A HINTON; J G TAGGART; J H ORR
Journal:  Can Med Assoc J       Date:  1960-09-24       Impact factor: 8.262

4.  The destruction of red cells by antibodies in man. I. Observations of the sequestration and lysis of red cells altered by immune mechanisms.

Authors:  J H JANDL; A R JONES; W B CASTLE
Journal:  J Clin Invest       Date:  1957-10       Impact factor: 14.808

5.  Idiopathic hemorrhagic gastritis.

Authors:  J CASTAGNO; R M HARDAWAY
Journal:  Ann Surg       Date:  1958-03       Impact factor: 12.969

6.  Pseudomembranous colitis.

Authors:  W V Bogomoletz
Journal:  J Clin Pathol       Date:  1977-06       Impact factor: 3.411

7.  Early mucosal changes in Crohn's disease.

Authors:  E A Sankey; A P Dhillon; A Anthony; A J Wakefield; R Sim; L More; M Hudson; A M Sawyerr; R E Pounder
Journal:  Gut       Date:  1993-03       Impact factor: 23.059

8.  Pseudomembranous colitis.

Authors:  A B Price; D R Davies
Journal:  J Clin Pathol       Date:  1977-01       Impact factor: 3.411

9.  The pseudomembranous colitis associated with clindamycin therapy--a viral colitis.

Authors:  H W Steer
Journal:  Gut       Date:  1975-09       Impact factor: 23.059
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.